Sequential Designs for Phase I Clinical Trials With Late-Onset Toxicities

Biometrics - United Kingdom
doi 10.1111/j.0006-341x.2000.01177.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Practical Modifications to the Time-To-Event Continual Reassessment Method for Phase I Cancer Trials With Fast Patient Accrual and Late-Onset Toxicities

Statistics in Medicine
EpidemiologyStatisticsProbability
2011English

Designs for Phase I Trials in Ordered Groups

Statistics in Medicine
EpidemiologyStatisticsProbability
2016English

Phase I Cancer Clinical Trials

British Journal of Cancer
Cancer ResearchOncology
2007English

A Dynamic Stopping Rule for Phase I Clinical Trials

Biometrical Letters
2018English

Bayesian Basket Designs for Cancer Clinical Trials

Japanese Journal of Biometrics
2019English

Adaptive Designs in Clinical Trials

English

Escalation With Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials

PLoS ONE
Multidisciplinary
2014English

A Dose-Schedule Finding Design for Phase I-Ii Clinical Trials

Journal of the Royal Statistical Society. Series C: Applied Statistics
UncertaintyStatisticsProbability
2015English

Isotonic Design for Phase I Clinical Trials: Can We Improve Further?

Austrian Journal of Statistics
UncertaintyApplied MathematicsStatisticsProbability
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy